Evidence map›Paper›PMID 30405294›Full record

Trial reportEthnicity & disease2018

Angiotensin II and the Natriuretic and Blood Pressure Response to Mental Stress in African Americans.

Gregory A Harshfield, Coral D Hanevold, Allison Jasti, Santu Ghosh, Jennifer Pollock, David Pollock, Frank A Treiber, Yanbin Dong, Varghese George

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Ethnicity & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Salt sensitivity of blood pressure in childhood and adolescence.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Gregory A HarshfieldGeorgia Prevention Institute, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA.
Coral D HanevoldDivision of Nephrology, Department of Pediatrics, University of Washington, Seattle, WA.
Allison JastiGeorgia Prevention Institute, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA.
Santu GhoshDivision of Biostatistics and Data Science, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA.
Jennifer PollockDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
David PollockDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Frank A TreiberColleges of Medicine and Nursing, Medical University of South Carolina, Charleston, SC.
Yanbin DongGeorgia Prevention Institute, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA.
Varghese GeorgeDivision of Biostatistics and Data Science, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA.
Augusta University · USUniversity of Alabama at Birmingham · USMedical University of South Carolina · USPrevention Institute · USUniversity of Washington · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

Objective: To test the hypothesis that Angiotensin II (Ang II) is a contributing factor to the response pattern in African Americans (AAs) who retain rather than excrete sodium during mental stress. Design/Study Participants: Double-blind, randomized, cross-over trial of 87 healthy AAs aged 18 to 50 years. Interventions: The study participants received either a placebo or irbesartan, (150 mg PO), an Ang II receptor antagonist, for seven days prior to stress testing. Urinary sodium excretion (UNaV) and systolic blood pressure (SBP) were collected prior to and throughout a mental stress protocol (rest and stress period). Setting: A southeastern university. Main Outcome Measures: Ang II, SBP, and sodium retention. Results: During the placebo condition, 62 participants showed the expected increase in UNaV (excreters) while 25 participants reduced UNaV during stress (retainers). Irbesartan retainers demonstrated a reversal in the direction of their natriuretic response, now increasing UNaV in response to stress (∆ UNaV of -.094 mmol/min with placebo vs .052 mmol/min on irbesartan; P<.001). In excreters, irbesartan reduced SBP levels during both rest (-2.36 mm Hg; P=.03) and stress (-4.59;P<.0001), and an even more pronounced reduction in SBP was demonstrated by retainers on treatment during both rest (-4.29 mm Hg; P=.03) and stress (-6.12; P<.001). Conclusions: Ang II contributes to sodium retention in retainers. Furthermore, our findings indicate that suppression of Ang II has a beneficial effect on SBP during rest and stress in this population.

Indexed as

SodiumStress, PsychologicalAdultAngiotensin IIAngiotensin Receptor AntagonistsBlack or African AmericanBlood PressureCross-Over StudiesDiureticsDouble-Blind MethodHealthy VolunteersHumansIrbesartanMaleMiddle AgedRenal EliminationAngiotensin IIAngiotensin Receptor AntagonistsDiureticsIrbesartanSodiumAngiotensin IIExcretersIrbesartanRetainersSodium RetentionStressSystolic Blood Pressure

Identifiers

PMID30405294
PMCPMC6200309
OpenAlexW2896414813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.